CD8A and neoplasm: M1 shifted GAMs were shown to induce anti-tumorgenic responses by altering the immune landscape through increasing CD8+ populations while simultaneously decreasing Treg populations, although, only mild improvements in animal survival and tumor burden were observed [57].